pyrrolidonecarboxylic acid has been researched along with Carcinoma, Pancreatic Ductal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, B; Guan, X; Hao, C; Liu, D; Tian, X; Wang, W; Wu, J; Yan, L; Zhao, M | 1 |
1 other study(ies) available for pyrrolidonecarboxylic acid and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Identification of the γ-glutamyl cycle as a novel therapeutic target and 5-oxoproline as a new biomarker for diagnosing pancreatic cancer.
Topics: Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Humans; Pancreatic Neoplasms; Pyrrolidonecarboxylic Acid; Tumor Microenvironment | 2023 |